Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages
- 1 January 1993
- journal article
- research article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism
- Vol. 1165 (3), 335-338
- https://doi.org/10.1016/0005-2760(93)90145-y
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytesPharmacological Research, 1991
- The Human Neutrophil Respiratory Burst OxidaseThe Journal of Infectious Diseases, 1990
- Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteinsAtherosclerosis, 1990
- Regulation of the mevalonate pathwayNature, 1990
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- LovastatinDrugs, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Uptake and degradation of low density lipoprotein by swine arterial smooth muscle cells with inhibition of cholesterol biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUMJCI Insight, 1955